A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. [electronic resource]
Producer: 19990223Description: 2677-89 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Bone Marrow -- drug effects
- DNA Topoisomerases, Type I -- metabolism
- Female
- Humans
- Leukocyte Count -- drug effects
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Risk Factors
- Topoisomerase I Inhibitors
- Topotecan -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.